Microglia over-activation contributes to neurodegenerative processes by neurotoxin factors and pro-inflammatory molecules of pro-inflammatory processes. Mitochondrial reactive oxygen species (ROS) and autophagy pathway might be involved in microglial activation, but the underlying mechanism is unclear. Here, we regulated autophagy pathway of microglia in vitro by autophagy inhibition (3-methyladenine treatment, siRNA-Beclin 1 or siRNA-ATG5 transfection) or induction (rapamycin treatment) in murine microglial BV-2 cells or cultured primary mouse microglial cells. And we found that autophagy inhibition could sensitize mitochondrial profile and microglial activation of cultured microglial cells, demonstrated by significant production of mitochondrial ROS, loss of mitochondrial membrane potential, secretion of pro-inflammatory cytokines including interleukin 1b (IL-1b), interleukin 6 (IL-6), interleukin 12 (IL-12) and tumor necrosis factor a and marked activation of mitogen-activated proteinkinases (MAPKs) and nuclear factor jB (NF-jB). These effects could be blocked by specific inhibitors of MAPK and NF-jB or mitochondrial antioxidants, Mito-TEMPO. Meanwhile, induction of autophagy with rapamycin treatment could significantly suppress microglial inflammatory responses, mitochondrial ROS production, activation of MAPKs and NF-jB. Taken together, our in vitro results from primary cultured microglia and BV-2 cell lines indicated that autophagy inhibition might participate in brain macrophage or microglia over-activation and mitochondrial ROS generation might be involved in the regulatory microglial pro-inflammatory responses.
Microglial cells are resident macrophages in the central nervous system (CNS), which can monitor surrounding environment, promote synaptogenesis and regulate the integrity of the blood-brain barrier and play important roles in CNS development, maintenance, and disease (BitzerQuintero and Gonz alez-Burgos 2012; da Fonseca et al. 2014; Bilimoria and Stevens 2015) . In the case of brain injury or disturbance of CNS homeostasis, microglia become activated and assist repairing and regrowth of compromised neurons by releasing various metabolites, growth factors, and cytokines (Doty et al. 2015; Lourbopoulos et al. 2015) . However, prolonged or excessive microglial activation becomes maladaptive and many pro-inflammatory cytokines and cytotoxic mediators such as tumor necrosis factor-a, interleukin-1b (IL-1b) and reactive oxygen species (ROS) are produced by activated microglia, which have been demonstrated to be cytotoxic and injurious to neurons and result in CNS diseases (Jurgens and Johnson 2012; Chhor et al. 2013; Doty et al. 2015; Xu et al. 2016) . Many studies have demonstrated the initial regulatory role of nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase, NOX) derived ROS pathways in microglial activation and mitogen-activated protein kinase (MAPK)s and nuclear factor jB (NF-jB) are the key downstream signals in activating microglia and pro-inflammatory factors production and reactive microgliosis (Pang et al. 2012; Nayernia et al. 2014; Rojo et al. 2014; von Bernhardi et al. 2015) . In addition to NADPH oxidase, nicotinamide adenine dinucleotide phosphate-oxidase-derived ROS, recent researchers have found that mitochondria constitute a major source of ROS generation in lipopolysaccharide (LPS)-mediated activation of microglia cells, and mitochondrial ROS are important for modulating immunoreactions and MAPK activation of immune response of microglia (Yokoyama et al. 2011; Bordt and Polster 2014; Park et al. 2015) . Reducing mitochondrial ROS or suppression of the redox pathway may be helpful for alleviating over-activation of microglial cells (Park et al. 2015; Ye et al. 2015) . However, the detailed mechanisms underlying microglial activation need to be further investigated.
Autophagy is an intracellular conserved process that sequesters long-lived proteins and dysfunctional cytoplasmic organelles, and transports them to lysosomes for degradation to maintain cellular homeostasis and avoid cellular damage (Galluzzi et al. 2014; Menzies et al. 2015; Xilouri and Stefanis 2015) . As a major source of ROS production, mitochondria is especially prone to ROS damage, which can induce mitochondrial permeability transition by opening non-specific high conductance permeability transition pores in the mitochondrial inner membrane and lead to cell injury (Perfeito et al. 2013) . To avoid cellular damage, ROSgenerating mitochondria are predominantly sequestered by autophagy and delivered to lysosomes for hydrolytic degradation specifically, which is called mitophagy (Lemasters 2005; Kim et al. 2007; Kurihara et al. 2012) . The autophagy-dependent degradation of mitochondria (mitophagy) is thought to play an important role in mitochondrial quality in mammalian cells by eliminating damaged mitochondria selectively Kurihara et al. 2012) . Dysfunction of mitophagic process may cause excess ROS production and related disease (Dagda et al. 2008 (Dagda et al. , 2009 Lizama-Manibusan and McLaughlin 2013; Li et al. 2015) . Kurihara et al. (2012) have identified the physiological relevance of mitophagy in yeast, and they found that when yeast cells in respiratory growth encountered nitrogen starvation, the cells initiated mitophagy, degraded excess mitochondria, and suppressed ROS production from mitochondria; as a result, the cells escaped the severe oxidative damage that causes mtDNA deletion (Kurihara et al. 2012) . Han et al. (2013) examined the role of the autophagy pathway in activated BV2 microglia cells and found that microglia possessed typical autophagy pathway, and the activation of the autophagy pathway suppressed the expression of inducible nitric oxide synthase and interleukin 6 (IL-6), and the cell death of LPS-stimulated microglia. Inhibition of autophagy might induce accumulation of ROS-producing damaged mitochondrial and lead to activation of microglia.
To test the hypothesis that autophagy might serve as a control mechanism to limit further mitochondrial ROS production and microglial activation, here we used primary cultured microglial cells and BV-2 cell lines as in vitro cell model and we interfered in microglial autophagy process by 3-methyladenine (3-MA, inhibitor of autophagy) treatment, Beclin 1 siRNA or ATG5 siRNA (key proteins in autophagy) in microglia. We observed microglial activation, mitochondrial profile including mitochondrial ROS production, mitochondrial membrane potential and mitochondrial ultrastructure of microglial cells. We also investigated the proinflammatory cytokine release, MAPK and NF-кB activation of microglia. Furthermore, the effects of rapamycin (RAP, an inducer of autophagy) and mito-TEMPO (a specific mitochondrial antioxidant) on mitochondrial ROS and microglial inflammatory responses of microglial cells were investigated in LPS-stimulated murine microglial cells.
Materials and methods
Chemicals and reagents 3-(4, 5-dimethylthiazol-2-yl)-2-5-diphenyl-tetrazolium bromide (MTT), Propidium iodide, RAP, 3-methyladenine (3-MA), LPS and mitochondria-targeted superoxide dismutase mimetic (Mito-TEMPO) were obtained from Sigma (St. Louis, MO, USA). Mitotracker deep red, Mitotracker green and MitoSOX Red were purchased from Invitrogen, Carlsbad, CA, USA. The phosphorspecific ERK1/2 (RRID: AB_653182), c-Jun N-terminal protein kinase (JNK) (RRID: AB_ AB_654354) and p38 (RRID: AB_2139810) antibodies, total (unphosphorylated) ERK1/2 (RRID: AB_2571739), JNK1/2(RRID: AB_632382) and p38 (RRID: AB_653716) antibodies, NF-кB/p65 (RRID: AB_632037) and anti-phospho-NF-кB/p65 antibodies (RRID: AB_2179018), Beclin 1 (RRID: AB_626745), ATG5 (RRID: AB_2243288) antib-actin antibody (RRID: AB_2223228), Lamin B antibody (RRID: AB_648154), anti-mouse IgG HRP-linked and anti-rabbit IgG HRP-linked secondary antibodies (RRID: AB_650499 and RRID: AB_628497) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). PD98059, SB203580, SP600125 and NF-кB inhibitor ammonium pyrrolidine dithiocarbamate (APDC) were purchased from Calbiochem (Darmstadt, Germany). Dulbecco'smodified Eagle's medium (DMEM) containing L-arginine (200 mg/L), fetal bovine serum, and other tissue culture reagents were purchased from Gibco (Grand Island, NY, USA). The ATG5 (mouse, sc-41446) and Beclin 1 siRNAs (mouse, sc-29798) were purchased from Santa Cruz Biotechnology along with control siRNA (sc-44230).
Cell culture
Primary microglial cell cultures were separated from 1 to 3 day old C57Bl/6 mice (Qingdao Institute for Drug Control, Shandong, China), and the procedures were prepared as described previously with some modifications (Giulian and Baker 1986) . Both sexes were used to prepare cell cultures. The animal protocols used in this study were approved by the Animal Research Committee of the Medical College of Qingdao University in compliance with institutional guidelines (Permit Number: 2010-0025) , in accordance with The Chinese Ministry of Science and Technology Guidelines on the Humane Treatment of Laboratory Animals (vGKFCZ-2006-398) and National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No.85-23, revised 1985) . Cerebral cortices were isolated, meninges were removed, and tissue was minced in the presence of DNAse I (50 lg/mL, Sigma). Cell suspension was filtered with a 40 lm cell strainer and plated in 75-cm 2 flasks precoated with poly-L-lysine (0.1 mg/mL; Sigma) at a density of 5 9 10 7 cells per flask. 
Transmission electron microscopy
Cell morphological changes and autophagy were observed under transmission electron microscopy (TEM). Briefly, cultured microglial cells were initially plated in triplicate at a density of 5 9 10 5 cells /well in six-well plates with different treatment. Cells were collected into eppendorff tubes and then fixed by 2.5% glutaraldehyde at 4°C. 24 h later, microglia were washed by PBS, fixed by osmic acid, then washed by distilled water, and dehydrated by dimethylketone. After embedment in Epon-812, the sample was cut into ultrathin sections (70 nm). The ultrathin sections were dyed with uranium acetate and plumbum citrate and examined with JEM-1200EX electron microscopy. The numbers of autophagasomes at a magnification of 920 000 were counted by an independent experimenter blinded to the experiment conditions, then combined for each cell. The mean numbers of ten random selected cells were obtained from serial sections.
ELISAs for TNF-a, IL-1b, IL-6, and IL-12 The amount of tumor necrosis factor a (TNF-a), IL-1b, IL-6 and interleukin 12 (IL-12) was measured using ELISA kits purchased from R&D Systems (Minneapolis, MN, USA) following the manufacturer's instruction. Briefly, standards and samples were added to a 96-well ELISA plate precoated with biotinylated anti-TNF-a, anti-IL-1b, anti-IL-6 or anti-IL-12 antibody. Then the unbound substances were washed away, and the enzyme-linked polyclonal antibodies specific for TNF-a, IL-1b, IL-6 or IL-12 were added to the wells, respectively. The wells were incubated for 2 h and then washed four times and filled with the substrate solution for an incubation of 30 min. The reaction was terminated by the stop solution. Absorbance was read at 450 nm in a microplate reader. The concentration of each sample was calculated from the standard curve prepared using the cytokine standards. Three wells were treated per experiment. The concentrations of the cytokines and growth factor were calculated in pg/mL protein.
Western blotting
For the quantification of protein expression, western blot analysis was used. Microglial cells in six-well plates were incubated and stimulated as described above. Cells were washed with ice cold PBS and lysed with Radio-Immunoprecipitation Assay (RIPA)-Buffer (150 mM NaCl, 10 mM Tris, 0.1% SDS, 1% Triton-X-100, 1% Deoxycholate, 5 mM EDTA, pH 7.4) with protease inhibitors (04693159001; Roche Molecular Biochemicals, Indianapolis, IN, USA). Nuclear and cytosolic extracts of microglial cells were prepared by lysing cells with Igepal CA-630 followed by differential centrifugation. Whole cell lysates were electrophoresed (SDS/ polyacrylamide gel electrophoresis), transferred to polyacrylamide gels, and immunoblotted using antibodies directed against appropriate antibodies: for ERK ( (1 : 1000, Santa Cruz) and b-actin (1 : 1000, Santa Cruz) and Lamin B (1 : 1000, Santa Cruz). Immunoblot analysis was performed with horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG using enhanced chemiluminescence western blotting detection reagents (Amersham Bioscience, Piscataway, NJ, USA). The bands were scanned and densitometrically analyzed using an automatic image analysis system (Alpha Innotech Corporation, San Leandro, CA, USA). These quantitative analyses were normalized to b-actin or Lamin B (after stripping).
Statistical analysis
All quantitative data and experiments described in this study were repeated at least three times. All analyses were performed blinded such that experimenters performing data analysis were unaware of the treatments. Data were expressed as means AE SEM. The criterion for statistical significance was p < 0.05. Bartlett's tests showed no significant differences in group variances; therefore, data were evaluated using parametric statistics. Comparisons between the different groups were performed by two-way or one-way ANOVAs followed by a Tukey's post hoc test for comparison among means. All data were analyzed using GRAPHPAD PRISM (GraphPad Software Inc., La Jolla, CA, USA) data analysis software.
Results

3-MA induced mitochondrial ROS production and inflammatory cytokines secretion in microglial cells
To investigate the role of autophagy and mitochondrial ROS in inflammatory responses of microglial cells, cells were treated with different concentrations of 3-MA (5-20 mM, a classic autophagy inhibitor) to inhibit autophagy process of microglial cells. Microglial inflammatory responses and changes in mitochondrial profile including mitochondrial ROS production and mitochondrial membrane potential were observed. Mitochondrial ROS production was measured using MitoSOX RED staining, which can be selectively oxidized by superoxide anion in the mitochondria.
Mitochondrial membrane potential was measured using two types of mitochondrial-specific probe that distinguish respiring mitochondria (Mitotracker deep red, which accumulation is dependent upon membrane potential), total mitochondria (Mitotracker green, which appears to localize to mitochondria regardless of mitochondrial membrane potential). FACS assays showed that 3-MA treatment results in the increase in the concentrations of mitochondrial ROS in microglial cells (Fig. 1a and Fig. S1 ), paralleled by the dose-dependent loss of mitochondrial membrane potential (Fig. 1b) , while cotreated microglia with mitochondrion-specific antioxidant Mito-TEMPO(200 lM)and 3-MA for 24 h could effectively reduce 3-MA-induced mitochondrial ROS production and loss of mitochondrial membrane potential in BV-2 microglial cells. ELISA assays indicated that microglial cells treated with 3-MA induced inflammatory responses characterized with the increase in the levels of cytokines, TNF-a and IL1b, IL-6 and IL-12 in a dose-dependent manner, which could be inhibited by the Mito-TEMPO (Fig. 2) .
Autophagy proteins ATG5 and beclin1 siRNA transfection sensitized mitochondrial profile and microglial activation induced by LPS To avoid the off-target effects of 3-MA, we next inhibited autophagy through downregulation of two key proteins of BV-2 cells by small interfering RNA of Beclin and ATG5 respectively. Protein knockdown in beclin1 siRNA or ATG5 siRNA transfected cells were confirmed by western blot analysis ( Fig. S2a and b) . In contrast to pharmacological inhibitors, beclin1 siRNA or ATG5 siRNA transfection showed no significant effects on basal mitochondrial ROS level and mitochondrial membrane potential loss and spontaneous inflammatory cytokines production in BV-2 cells (Figs 3 and 4). So we next interfered autophagy process in LPS-treated BV-2 cell model (Figs 3 and 4). Determined by MitoSOX RED, Mitotracker deep red and Mitotracker green staining and ELISA assays, control siRNA transfected microglial cells treated with 100 ng/mL LPS showed significant mitochondrial ROS production, loss of mitochondrial membrane potential and inflammatory cytokines production, which confirmed that LPS might activate microglial cells by dramatically inducing mitochondrial ROS production and leading to mitochondrial damage. Inhibition of mitophagy/ autophagy by beclin 1 siRNA or ATG5 siRNA sensitized microglial cells to LPS stimulation, which presented as more significant production of mitochondrial ROS, more loss of mitochondrial membrane potential and release of inflammatory cytokines in beclin 1 siRNA or ATG5 siRNA transfected cells compared to negative siRNA transfected controls. And this augmented response was not accompanied by increased cell death (Fig. S2c) . Transmission electron microscopy (TEM) confirmed enhanced autophagy in LPS activated microglial cells accompanied by the formation of autophagic vacuoles enveloping cytoplasm, mitochondria, and endoplasmic reticulum, while beclin 1 siRNA or ATG5 siRNA transfected BV-2 cells treated with LPS showed less autophagasomes (Figs 3d and 4d, Fig. S3a and b) . It is therefore rational that a functional mitophagy/ autophagy system acts as a scavenger of mitochondrial ROS through removal of damaged mitochondria and thereby suppresses inflammatory responses of microglial cells.
Autophagy induction by rapamycin inhibited LPS-induced microglial activation through mitochondrial pathway
To further confirm that autophagy regulated microglial inflammatory responses through mitochondrial pathway, we determined the effect of rapamycin, a known autophagy inducer, on mitochondrial profile in LPS-activated microglia. Microglial cells were incubated with LPS (100 ng/mL) in the absence or presence of 100 nM rapamycin for 24 h, and mitochondrial ROS production, mitochondrial membrane potential, and inflammatory cytokines production was observed. Rapamycin not only decreased the basal level of mitochondrial ROS production in microglial cells but also significantly suppressed LPS-mediated mitochondrial ROS production and mitochondrial membrane potential decrease ( Fig. 5a and b) . Meanwhile, secretion of TNF, IL-1b, IL-6, and IL-12 by LPS-treated microglial cells were inhibited by rapamycin treatment (Fig. 5c ). Transmission electron microscopy (TEM) confirmed that microglia treated with LPS and rapamycin showed more autophagasomes filled with degraded organelles than LPS-treated alone ( Fig. 5d and Fig. S3c ). Taken together, these results indicated that mitochondrial ROS induced by LPS triggered autophagy and induction of autophagy by rapamycin helped to remove ROS-generating mitochondria. It is consistent with the notion that the induction of autophagy protects cells against LPS toxicity, potentially through the amelioration of ROS production.
Mitochondrial antioxidants Mito-TEMPO suppressed autophagy activation induced by LPS Oxidative stress may activate process of autophagy and ROS-generating mitochondrial is constantly removed by autophagy to avoid cellular damage or produce inflammatory responses. To determine whether mitochondrial ROS is involved in induction of autophagy and inflammatory responses during microglia activation, we treated LPSactivated microglia with mitochondrion-specific antioxidant Mito-TEMPO for 24 h to reduce mitochondrial ROS levels. Coincubation of microglial cells with Mito-TEMPO (200 lM)dramatically blocked LPS-induced mitochondrial ROS production and loss of mitochondrial membrane potential ( Fig. 6a and b) . Mito-TEMPO also consistently inhibited enhanced autophagy marked with the expression of beclin1, ATG5, and LC3-IIand production of inflammatory cytokines in microglial cells (Fig. 6c and d) . These results partly suggested that mitochondrial ROS play an important role in inducing autophagy and inflammatory responses of LPS-treated microglial cells. (TNF-a) , IL-1b, IL-6 and IL-12 in the culture medium of microglia was measured by ELISA. Each bar represents the mean AE SEM from five independent experiments. The concentration of each sample was calculated from the standard curve prepared using the cytokine standards and growth factor were calculated in pg/ml protein. Two-way ANOVAs followed by a Tukey's post hoc test. n = 5. *p < 0.05, compared to non-treated control cells, # p < 0.05 compared to corresponding control cells. Fig. 3 Effects of autophagy inhibition by Beclin 1 siRNA transfection on mitochondrial reactive oxygen species (ROS) production, mitochondrial membrane potential, pro-inflammatory cytokine secretion and mitochondrial morphology in lipopolysaccharide (LPS)-treated microglia. BV-2 cells were transfected with 50 nM Beclin 1 siRNA or control siRNA (non-targeting siRNA) for 24 h before treatment with LPS (100 ng/mL). (a) Mitochondrial ROS production was evaluated by quantitatively analyses of MitoSOX Red fluorescence signal intensity by flow cytometry. Data were represented as intensity of ROS production of cells. Each bar represents the mean AE SEM from four independent experiments. One-way ANOVAs followed by a Tukey's post hoc test. n = 4. **p < 0.01 compared to control siRNA-transfected control cells. (TNF-a) , IL-1b, IL-6 and IL-12 in the culture medium of microglia was measured by ELISA. Each bar represents the mean AE SEM from five independent experiments. One-way ANOVAs followed by a Tukey's post hoc test. n = 5. **p < 0.01 compared to control siRNA-transfected control cells. Morphological mitochondrial ultrastructural changes in BV-2 cells were observed under transmission electric microscopy. The mitochondria of control cells were characterized by folded cristae and voluminous intracristal spaces embedded in an electron dense, homogeneous matrix. Fewer numbers of elongated and swelling mitochondrial profiles and less autophagic vacuoles were observed in Beclin 1 siRNA-transfected cells than those cells treated only with LPS. Black arrows were used to label autophagosomes and asterisks were used to label mitochondria. Scale bars = 1 lm. Fig. 4 Effects of autophagy inhibition by ATG5 siRNA transfection on mitochondrial reactive oxygen species (ROS) production, mitochondrial membrane potential, pro-inflammatory cytokine secretion and mitochondrial morphology in microglia. BV-2 cells were transfected with 50 nM ATG5 siRNA or control siRNA (non-targeting siRNA) for 24 h before treatment with lipopolysaccharide (LPS) (100 ng/mL). (a) The mitochondrial ROS production was evaluated by quantitatively analyses of MitoSOX Red fluorescence signal intensity by flow cytometry. The data were represented as intensity of ROS production of cells. Each bar represents the mean AESEM from four independent experiments. One-way ANOVAs followed by a Tukey's post hoc test. n = 4. **p < 0.01 compared to control siRNA-transfected control cells. (c) Secretion of tumor necrosis factor a (TNF-a), IL-1b, IL-6 and IL-12 in the culture medium of microglia was measured by ELISA. Each bar represents the mean AES.E.M from five independent experiments. One-way ANOVAs followed by a Tukey's post hoc test. n = 5. **p < 0.01 compared to control siRNA-transfected control cells. ## p < 0.01 compared to LPS + Control siRNA-treated cells. (d) Morphological mitochondrial ultrastructural changes in BV-2 cells were observed under transmission electric microscopy. The increased numbers of elongated and swelling mitochondrial profiles and some autophagic vacuoles were observed in LPS-treated alone microglial cells and ATG5 siRNA transfection showed less autophagic vacuoles than that in LPS-treated alone microglial cells. Black arrows were used to label autophagosomes and asterisks were used to label mitochondria. Scale bars = 1 lm.
2014; Park et al. 2015) . Therefore, we investigated the activity of p38, JNK, ERK, and NF-jB in activated BV-2 cells when enhancing or blocking autophagy by rapamycin, 3-MA treatment or Beclin siRNA, ATG5 siRNA transfection (Figs 7 and 8, Fig. S4 and Fig. S5 ). Our results showed that inhibition of autophagy by 3-MA could activate p38, ERK, JNK, and NF-jB in microglial cells, which could be partially blocked by Mito-TEMPO coincubation (Fig. 7a and (c) Secretion of tumor necrosis factor a (TNF-a), IL-1b, IL-6 and IL-12 in the culture medium of microglia was measured by ELISA. Each bar represents the mean AESEM from five independent experiments. Oneway ANOVAs followed by a Tukey's post hoc test. n = 5. **p < 0.01 compared to control siRNA-transfected control cells. S4 ). Rapamycin treatment could effectively inhibit the MAPK and NF-jB activity stimulated by LPS (Fig. 7b and Fig. S4 ). Inhibition of autophagy in LPS-treated BV-2 cells by Beclin siRNA, ATG5 siRNA could stimulate more significant p38, ERK, JNK, and NF-jB activation than LPS alone treated cells and the stimulatory effects could be partly inhibited by Mito-TEMPO coincubation (Fig. 8a and b and Fig. S5 ). Furthermore, production of pro-inflammatory cytokines in BV2 cells induced by inhibition of autophagy could be partly inhibited by MAPKs and NF-jB specific inhibitors, respectively (SB203580, specific p38 inhibitor; PD98059, specific ERK1/2 inhibitor; SP600125, specific JNK inhibitor; APDC, NF-кB inhibitor) (Fig. 9) . Altogether, these results suggested that MAPK-NF-кB pathways may be involved in mitochondrial ROS mediated inflammatory responses in microglia induced by autophagy inhibition.
Discussion
Autophagy is the crucial process for recycling cellular organelles, for the cell's survival and activating microglia (Franc ßois et al. 2013; Han et al. 2013) . Autophagy pathway might be involved in the production of pro-inflammatory cytokines and cytotoxic factors in microglia; however, the detailed mechanisms of its regulatory activities remain unknown. Here, we first observed the role of autophagy in microglial inflammatory responses in vitro by modulating autophagy process using autophagy inhibitor, 3-MA. The results showed that 3-MA treatment result in the secretion of pro-inflammatory cytokines including TNF-a, IL-1b, IL-6, and IL-12 both in murine microglial BV-2 cells and primary mouse microglia, which suggested that autophagy inhibition by 3-MA may induce microglial pro-inflammatory responses. Autophagy plays an essential role in maintaining mitochondrial structure, functional and genetic integrity by delivering ROS-generating, aged and dysfunctional mitochondria to lysosomes for hydrolytic degradation specifically. Dysfunction of autophagy process may induce the defective turnover of mitochondria, which result in the accumulation of damaged mitochondria accompanied by increasing ROS production (Lemasters 2005; Kim et al. 2007; Kurihara et al. 2012) . In line with these findings, our present study showed that 3-MA treatment effectively increased mitochondrial ROS production and led to loss of mitochondrial membrane potential in a dose-dependent manner and increased microglial inflammatory cytokines production could be blocked by mitochondrion-specific antioxidant Mito-TEMPO cotreatment, which suggested that mitochondrial ROS partly involved in 3-MA-induced microglial activation. Few studies have reported the diverse effects of 3-MA on microglial activity in vitro and in vivo (Yang et al. 2014a (Yang et al. ,b, 2015 Guo et al. 2015; Yang et al. 2015; Bie et al. 2015) . Our present observations were basically in consistent with the studies reported by Bie et al. (Bie et al. 2015) , which found that 3-MA could inhibit the protective effects of a natural compound Lycium barbarum polysaccharide on bipolar pulse current-induced microglia cell injury through endogenous autophagy inhibition. However, our present data were somehow different from several other published in vitro and in vivo studies (Yang et al. 2014a (Yang et al. ,b, 2015 Guo et al. 2015) , in which 3-MA treatment showed protective effects on microglial cell death against hypoxia or cocaine stimuli through inhibiting autophagy pathways and microglial inflammatory response. The different effects of 3-MA on microglial activation may be attributed to the difference in cell model, types of stimuli, the state of microglial cells, and dose and time of 3-MA incubation.
To further investigate the role of autophagy in microglial activation and avoid the off-target effects of 3-MA, we inhibited autophagy through down-regulation of two proteins of BV-2 cells by small interfering RNA of Beclin 1 and ATG5 respectively. Beclin1 has been demonstrated to be a key factor in the activation and initiation of the autophagy by enhancing vesicle nucleation and ATG5 is crucial for the formation of autophagic vesicles (Suzuki et al. 2001; Mizushima 2011) . Although studies have reported the pivotal role of Beclin1 and ATG in regulating autophagy in microglia (Lucin et al. 2013 ; O'Brien and Wyss-Coray 2014), our results showed that Beclin 1 siRNA and ATG5 siRNA transfection have slight effects on microglial cells under physiological conditions and no significant changes in basal mitochondrial ROS level, mitochondrial membrane potential loss and spontaneous inflammatory cytokines production in BV-2 cells were observed. However, when microglia cells were exposed to LPS, a well-known activator of microglia, we observed more significant production of mitochondrial ROS, more loss of mitochondrial membrane potential and more release of inflammatory cytokines in beclin 1 siRNA or ATG5 siRNA transfected cells compared to negative siRNA transfected controls. These results suggested that in LPS-stimulated microglial cells, inappropriate autophagy signaling may implicate in microglial overactivation and partly confirmed the effects of 3-MA on mitochondrial profile and microglial inflammatory responses, which further demonstrated the crucial role of autophagy maintenance of metabolic homeostasis in microglia.
Functional mitophagy/ autophagy system may act as a scavenger of mitochondrial ROS through the removal of damaged mitochondria and thereby suppresses inflammatory responses of microglial cells. It has been found that autophagy inducer, rapamycin is a novel neuroprotective therapy against traumatic brain injury in vivo models via modulation of microglial activation (Erlich et al. 2007; Song et al. 2015) . Studies have found that microglia possessed typical autophagy pathway in LPS-stimulated BV2 cells and the activation of the autophagy pathway by rapamycin, an autophagy inducer could efficiently suppresses the expression of inducible nitric oxide synthase and IL-6 and the cell death induced by LPS (Han et al. 2013) . Our present study observed the effects of rapamycin on mitochondrial profile in LPS-activated microglia and the results showed that rapamycin not only decreased the basal level of mitochondrial ROS production in microglial cells but also significantly suppressed LPS-mediated mitochondrial ROS production, the potential decrease in mitochondrial membrane and secretion of inflammatory cytokines, which indicated that the induction of autophagy protects cells against LPS toxicity, potentially through the amelioration of mitochondrial ROS production. Meanwhile, we also found that enhanced autophagy characterized the expression of beclin1, ATG5 and LC3-,IIand production of inflammatory cytokines in LPS-treated microglial cells could be blocked by Mito-TEMPO coincubation, which partly suggested that mitochondrial ROS play an important role in inducing autophagy and inflammatory responses of LPS-treated microglial cells. However, in this study we could not attribute the effects of Fig. 9 The role of mitogen-activated protein kinase (MAPK) or NF-jB signaling on autophagy inhibition-mediated pro-inflammatory cytokine secretion by cultured microglia. BV-2 cells or Beclin 1 siRNA or ATG5 siRNA transfected BV-2 cells were pretreated with MAPK or NF-кB inhibitors, PD98059, SB203580, SP600125 and ammonium pyrrolidine dithiocarbamate (APDC), for 3 h, and then treated with 3-MA (10 nM) or lipopolysaccharide (LPS) (100 ng/mL) for 24 h. The mean concentration of tumor necrosis factor a (TNF-a), IL-1b, IL-6 and IL-12 in the culture medium of microglia was measured by ELISA. Each bar represents the mean AESEM from five independent experiments. The concentration of each sample was calculated from the standard curve prepared using the cytokine standards and growth factor were calculated in pg/mL protein. One-way ANOVAs followed by a Tukey's post hoc test. n = 5. **p < 0.01, compared to corresponding basal control cells. rapamycin on our cell models only to autophagy pathway as the mammalian target of rapamycin is a translation regulator important for cell growth, proliferation, and survival. Mammalian target of rapamycin inhibitor rapamycin may have other effects outside of autophagy including regulation of cell growth, proliferation, mRNA transcription and translation and cytoskeletal organization in the modulation of innate immune responses (Dello et al. 2009 ). Clinically rapamycin has been an approved drug used to prevent rejection of organ transplantation (Calne et al. 1989) . In microglia cultures stimulated with LPS, rapamycin reduced the expression of nitric oxide synthase, cyclooxygenase (COX)-2 and microsomal prostaglandin E synthase-1 (mPGES-1) (Dello et al. 2009; de Oliveira et al. 2012) . Also, rapamycin has been found as a direct inducer of M1 polarization of macrophages and microglia, it also strongly enhances Treg activity, which in turn restrains the inflammatory response of macrophages and microglia (Xie et al. 2014) . The direct mechanism of rapamycin on microglial activation need to be investigated in future study.
MAPKs and NF-jB are key ROS-regulated downstream signals in microglial activation and inflammatory responses (Jung et al. 2007; Bordt and Polster 2014; Park et al. 2015) . Some studies and our previous studies have demonstrated that mitochondrial ROS could regulate pro-inflammatory responses in microglia activation through MAPKs and NF-jB signal pathway (Jung et al. 2007; Ye et al. 2015) . Using specific antibodies, we found that both inhibition of autophagy by 3-MA treatment and Beclin siRNA, ATG5 siRNA transfection in LPS-treated BV-2 cells led to more significant p38, ERK, JNK, and NF-jB activation, and the stimulatory effects could be partly inhibited by Mito-TEMTO incubation. However, the inhibitory effects of Mito-TEMPO on MAPK and NF-jB activity in siRNA transfected BV-2 cells were partial and seemed less significant. These interesting results may be related to higher baseline of MAPK and NF-jB activity in siRNA transfected cells and the relatively lower dose of Mito-TEMPO that we chose (200 lM), as the effects Mito-TEMTO that we have tested in our preliminary experiments are dose-dependent. Of course, as autophagy seems to be downstream of mitochondrial ROS, the exact mechanisms of unequivalent effects of Mito-TEMPO should be explored future studies. Rapamycin treatment could effectively inhibit the MAPK and NF-jB activity stimulated by LPS. Furthermore, production of pro-inflammatory cytokines in BV2 cells induced by inhibition of autophagy could be partly inhibited by MAPKs and NF-jB specific inhibitors respectively (SB203580, specific p38 inhibitor; PD98059, specific ERK1/2 inhibitor; SP600125, specific JNK inhibitor; APDC, NF-кB inhibitor). Altogether, these results suggested that MAPK-NF-кB pathways mediated autophagy inhibition-induced inflammatory responses in microglia through mitochondrial ROS.
In our present in vitro study, we used cultured primary microglial cells and BV-2 immortalized murine microglial cell lines as cell models. However, considering the complexity of the in vivo growth and developmental environment, results obtained from in vitro experiments, after all, cannot predict the reaction of an entire organism in vivo, so the molecular profile of in vitro cultured microglia is different from in vivo microglia. Some researchers have found that cultured primary microglia and, particularly, BV2 cells are very different from in vivo microglia (Butovsky et al. 2014; Gosselin et al. 2014) . Gosselin et al. (2014) analyzed the transcriptomes and enhancer landscapes of brain microglia and resident macrophages of the peritoneal cavity, and they found that distinct tissue environments drive divergent programs of gene expression by differentially activating a common enhancer repertoire and by inducing the expression of divergent secondary transcription factors that collaborate with PU.1 to establish tissue-specific enhancers. Butovsky et al. (2014) found newborn microglia (P1), primary cultured newborn microglia (P1-P2), microglial cell lines (N9, BV2), embryonic stem cell microglia (ESdMs) 24 and RAW264.7 macrophages did not express the adult microglia signature they identified. At the same time, they also reported that embryonic and early post-natal microglia acquired the features of adult microglia after post-natal day four, possibly as newly-proliferated microglial cells began to express differentiated functions (Butovsky et al. 2014) . Unfortunately, the comparison of different gene expression in these cells that our present study involved (including IL1b, IL-6, IL-12, TNF-a, MAPKs, NF-jB, Beclin 1, ATG 5) were not found in existing literature. Further in vivo study on adult microglia should be performed in the future.
In conclusion, our present in vitro study first observed the regulatory role of autophagy between mitochondrial ROS production and the secretion of pro-inflammatory cytokines in cultured primary microglia and BV-2 cell lines by modulating autophagy pathway using autophagy inhibitor or inducer. Our results indicated that autophagy inhibition might induce mitochondrial ROS production, loss of mitochondrial membrane potential and contribute to inflammatory responses in cultured primary microglia and BV-2 cells in vitro. Meanwhile autophagy induction with rapamycin treatment could significantly suppress LPS-induced microglial activation. The data suggested the important regulatory function of autophagy in microglial activation and indicated that mitochondrial ROS may be the key mediator between autophagy and microglial inflammatory responses. Furthermore, mitochondrial ROS dependent MAPK and NF-jB signal pathways were found to be related to the activation of microglial cells induced by autophagy inhibition. Our study provided some useful information for understanding the role of autophagy in microglial activation and effective protections against mitochondrial ROS in excessive microglial activation. Further experiments should be carried out to explore the molecular mechanisms of autophagy on the signaling pathways of mitochondrial ROS-mediated microglial activation and the connection of mitochondria homeostasis with microglial inflammatory responses in vitro and in vivo.
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